Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Lanx CEO

You may also be interested in...



People In Brief

Gorsky assumes chairmanship at J&J. John Yonkin named CEO at Immunetics. More news on people in the device and diagnostics industries.

People In Brief

Alcon board changes

People In Brief

Lanx gets DeMane: Former Medtronic Chief Operating Officer Michael DeMane is now the chairman and CEO of spine device firm Lanx, the privately held company announced June 7. DeMane moves from his post at venture capital firm Thomas, McNerney and Partners, which he joined last year following his departure from Medtronic in 2008, when the firm eliminated its COO post (1"The Gray Sheet" May 5, 2008). He was an executive at Smith & Nephew and then spine firm Sofamor Danek Group until Medtronic acquired Sofamor in 1999. DeMane subsequently ran Medtronic's spinal systems business. In 2005, he took the helm of Medtronic's Europe, Canada, Latin America and Emerging Markets division, prior to becoming COO in 2007. Lanx markets 10 spinal fusion product lines, including the Telluride minimally invasive system and the BioLanx biologics line

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel